Used in pharmaceutical synthesis as a key intermediate for developing protease inhibitors, particularly in oncology research. Its boronic acid functional group enables reversible binding to enzyme active sites, making it valuable in targeted therapies such as those for certain cancers. Commonly employed in Suzuki-Miyaura cross-coupling reactions during drug discovery to build complex aromatic structures. Also utilized in the preparation of radiolabeled compounds for positron emission tomography (PET) imaging due to the presence of fluorine, allowing for non-invasive disease monitoring.